Farmako logo
HomeMedicine DeliveryABDM
Decorative illustration
HomeMedicine DeliveryABDM
footer illustration
HomePrivacy PolicyTerms & Conditions
Download the App
play-storeapp-store
Copyright Farmako Healthcare Private Limited © 2025 All rights reserved
facebooktwitterlinkedininstagram
medicine
medicine
medicine
medicine
medicine
medicine

Switglim MV 2/0.3 Tablet ER

strip of 10.0 tablet
Prescription Required
30 minute delivery
strip of 10.0 tablet
₹ 147.27
Get it on upto a 20% discount on Farmako
Delivering to
Out of Stock
Ask Life AI anything about this medicine
Tell me about medicines!

Manufacturer

Akumentis Healthcare Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)

Key InformationDirections for UseSafety InformationHow it worksQuick Tips

Manufacturer

Akumentis Healthcare Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)

Key Information

Short Description

Switglim MV 2/0.3 Tablet ER is a combination of medicines used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.

Dosage Form

Tablet ER

Introduction

Switglim MV 2/0.3 Tablet ER belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.

Directions for Use

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush, or break it. Switglim MV 2/0.3 Tablet ER is to be taken empty stomach.

Safety Information

Side Effects

No common side effects listed.

Alcohol Warning

Alcohol Warning

It is unsafe to consume alcohol with Switglim MV 2/0.3 Tablet ER.

Breastfeeding Warning

Breastfeeding Warning

Switglim MV 2/0.3 Tablet ER is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.

Pregnancy Warning

Pregnancy Warning

Switglim MV 2/0.3 Tablet ER may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

How it works

Switglim MV 2/0.3 Tablet ER is a combination of three antidiabetic medicines:

Quick Tips

Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol, or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).

Short Description

Switglim MV 2/0.3 Tablet ER is a combination of medicines used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.

Dosage Form

Tablet ER

Introduction

Switglim MV 2/0.3 Tablet ER belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush, or break it. Switglim MV 2/0.3 Tablet ER is to be taken empty stomach.

Side Effects

No common side effects listed.
Alcohol Warning

Alcohol Warning

It is unsafe to consume alcohol with Switglim MV 2/0.3 Tablet ER.
Breastfeeding Warning

Breastfeeding Warning

Switglim MV 2/0.3 Tablet ER is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Pregnancy Warning

Pregnancy Warning

Switglim MV 2/0.3 Tablet ER may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Switglim MV 2/0.3 Tablet ER is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol, or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).

Related Medicines

medicine

Trivolib Forte 2 Tablet

1 Strip of 15 Tablet
20% off1 Strip of 15 Tablet
₹ 256.00
20% off
medicine

Voglital GM 0.3 Tablet

1 Strip of 10 Tablet
20% off1 Strip of 10 Tablet
₹ 88.94
20% off
medicine

Gevel Trio 2 Tablet ER

strip of 15.0 tablet
20% offstrip of 15.0 tablet
₹ 229.00
20% off
medicine

Trivose 2 Tablet ER

strip of 15.0 tablet
20% offstrip of 15.0 tablet
₹ 260.00
20% off
medicine

Drmet GV/2 Tablet ER

strip of 10.0 tablet
20% offstrip of 10.0 tablet
₹ 48.00
20% off
medicine

Glipament MV 2 Tablet ER

strip of 10.0 tablet
20% offstrip of 10.0 tablet
₹ 120.00
20% off
medicine

Karbohold GM 2mg/500mg/0.3mg Tablet ER

strip of 10.0 tablet
20% offstrip of 10.0 tablet
₹ 189.00
20% off
medicine

Voglimend-GM 3 SR Tablet

strip of 10.0 tablet
20% offstrip of 10.0 tablet
₹ 100.00
20% off
medicine

Voglitum-Trio 0.3 Tablet ER

strip of 10.0 tablet
20% offstrip of 10.0 tablet
₹ 179.00
20% off
medicine

Qtoglym 0.3/2 Tablet ER

strip of 10.0 tablet
20% offstrip of 10.0 tablet
₹ 145.00
20% off

Frequently asked questions

What is Switglim MV 2/0.3 Tablet ER?

Switglim MV 2/0.3 Tablet ER is a combination medication containing Glimepiride, Metformin, and Voglibose. This medication is used to treat type 2 diabetes mellitus (DM). It improves blood glucose levels in adults when taken alongside proper diet and regular exercise. Glimepiride reduces blood sugar by increasing insulin release from the pancreas. Metformin lowers glucose production in the liver and enhances insulin sensitivity. Voglibose inhibits alpha-glucosidase, lowering postprandial glucose levels after meals. This combination is not indicated for Type 1 DM treatment.

What are the possible side effects of Switglim MV 2/0.3 Tablet ER?

Possible side effects of Switglim MV 2/0.3 Tablet ER include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infection.

Are there any specific conditions in which Switglim MV 2/0.3 Tablet ER should not be taken?

Switglim MV 2/0.3 Tablet ER must not be used by patients with known allergy to any of its components or excipients, and those with severe kidney disease, inflammatory bowel disease (IBD), colonic ulcers, or underlying metabolic acidosis including diabetic ketoacidosis.

Is it safe to take alcohol while I am also taking Switglim MV 2/0.3 Tablet ER?

No, taking alcohol with Switglim MV 2/0.3 Tablet ER is not advised. This combination can lower blood sugar levels (hypoglycemia) and increase the risk of lactic acidosis.

Can the use of Switglim MV 2/0.3 Tablet ER cause hypoglycemia?

Yes, Switglim MV 2/0.3 Tablet ER can cause hypoglycemia (low blood sugar level). Symptoms of hypoglycemia include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feelings of anxiety or shakiness. It is more likely to occur if you miss meals, drink alcohol, over-exercise, or take other antidiabetic medication simultaneously. Regular monitoring of blood sugar levels is crucial. Keep glucose tablets, honey, or fruit juice readily accessible.

What are the instructions for storage and disposal of Switglim MV 2/0.3 Tablet ER?

Store this medication in its original package or container, tightly closed. Follow instructions provided on the label or packaging. Discard unused medicine; do not give it to pets, children, or other people.

Switglim MV 2/0.3 Tablet ER is a combination medication containing Glimepiride, Metformin, and Voglibose. This medication is used to treat type 2 diabetes mellitus (DM). It improves blood glucose levels in adults when taken alongside proper diet and regular exercise. Glimepiride reduces blood sugar by increasing insulin release from the pancreas. Metformin lowers glucose production in the liver and enhances insulin sensitivity. Voglibose inhibits alpha-glucosidase, lowering postprandial glucose levels after meals. This combination is not indicated for Type 1 DM treatment.
Possible side effects of Switglim MV 2/0.3 Tablet ER include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infection.
Switglim MV 2/0.3 Tablet ER must not be used by patients with known allergy to any of its components or excipients, and those with severe kidney disease, inflammatory bowel disease (IBD), colonic ulcers, or underlying metabolic acidosis including diabetic ketoacidosis.
No, taking alcohol with Switglim MV 2/0.3 Tablet ER is not advised. This combination can lower blood sugar levels (hypoglycemia) and increase the risk of lactic acidosis.
Yes, Switglim MV 2/0.3 Tablet ER can cause hypoglycemia (low blood sugar level). Symptoms of hypoglycemia include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feelings of anxiety or shakiness. It is more likely to occur if you miss meals, drink alcohol, over-exercise, or take other antidiabetic medication simultaneously. Regular monitoring of blood sugar levels is crucial. Keep glucose tablets, honey, or fruit juice readily accessible.
Store this medication in its original package or container, tightly closed. Follow instructions provided on the label or packaging. Discard unused medicine; do not give it to pets, children, or other people.
India' first 30 minutes
medicine delivery service
percentage
Get atleast 20% discount on all medicines
shield
We always ensure genuine medicines and qualified doctors
deliver
Completed over 2 lakhs super-fast deliveries